Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 10

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych:  chemosensitivity
help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
1
Content available remote

The NHE3 inhibitor AVE1599 stimulates phrenic nerve activity in the rat

100%
The effect of AVE1599, an inhibitor of the sodium/proton exchanger type 3 (NHE3), on phrenic nerve (PN) activity was investigated using the working heart brainstem preparation (WHBP). Hypercapnia (pH: -0.1) applied for 10 min reversibly increased PN frequency (f) by 66.0 ± 19.5% and decreased burst duration by 23.3 ± 3% (mean ± SE, n = 21). Similarly, AVE1599 (0.3µM) increased f after 10 and 30 min by 75.1 ± 13.2 and 176 ± 36.2% (n = 10), respectively, and reduced duration of PN bursts by 24.9 ± 10.8%. Hypercapnia-induced increases of f were attenuated by AVE1599. An elevated concentration of AVE1599 (0.9µM) had no significant effect on PN. As AVE1599 accumulates in brain tissue and might interfere with the less affine NHE1, we furthermore tested the NHE1-inhibitor HOE642. In fact, HOE642 (0.9µM) diminished f by 88.5 ± 9.2 and 58.6 ± 10.0% after 10 and 30 min (n = 6), respectively, but did not abolish hypercapnic responses. We conclude that AVE1599 augments central respiratory drive in the WHBP via NHE3 but not NHE1 inhibition.
Background: The present study was performed to clarify fatigue-induced effects of a strenuous and moderate intensity endurance training session on temporary changes of cardiopulmonary (CP) chemosensitivity and fast kinetics response. Material/Methods: Eleven high performance (national level) male rowers participated in this study [age 21.8 ±1.7 (range 18-25 years), 89.3 ±2.0 kg, 190.1 ±1.7 cm, VO2 max 67.9 ±1.1 ml·kg-1·min-1]. The studies involved three steps: 1) a study of effects related to a training session of moderate intensity, 2) effects of a high intensity session, and 3) an impact of a high intensity session on values of peak response. The high intensity session consisted of intermittent training loads made up of five sets of four repetitions of sixty-second work intervals (HR of 149-186 bt·min-1). The moderate intensity session consisted of unvarying type of exercise (HR of 138-167 bt·min-1). Measurements were made at rest before, 13-15, and 37-39 hours after the training session. In rebreathing tests ventilatory sensitivity to CO2 and HR response sensitivity to normocapnic hypoxia were measured. Fast kinetics of ventilation, oxygen uptake, CO2 production and the heart rate were measured in a 5-min standard power test (0.7 VO2 max, 5 min, transition from 25 w) and in a 6-min test (1.12 ±0.11 VO2max). Results: We found that a training session of high intensity resulted in a significant decrease in sensitivity to hypercapnia, an increase in CP sensitivity to hypoxia, a decrease in CP fast kinetics and stability of peak response 13-15 hours after the session vs. baseline. Mean power in a 6-min maximum test decreased, which was mainly determined by a decrease in mean power during the first 3 min and utilization of VO2 max for a 6-min test. Moderate intensity of a training session resulted in an increase in ventilatory sensitivity to hypercapnia whereas sensitivity CP to hypoxia and fast kinetics remained unaffected. Conclusions: These results suggest that not only CP chemosensitivity to hypoxia but also CP chemosensitivity to hypercapnia are variable in high intensity endurance training. The variability related to the effect of fatigue in the recovery phase (up to 15-15 hours) after strenuous training sessions.
A pilot study on relationships of selected molecular factors [erbB-1, erbB-2, erbB-3, and c-myc oncogene average gene copy numbers (AGCN); steroid receptors and pS2 gene expression; tumor cells' DNA values] to the ex vivo chemosensitivity of ovarian cancer in a modified adenosine triphosphate cell viability chemosensitivity assay (ATP-CVA), was performed. Despite the relatively small number of patients, numerous correlations among the factors tested were found. Nevertheless, only c-myc gene dosage positively affected ex vivo chemosensitivity of tumors tested.
A pilot study on relationships of selected molecular factors (c-myc oncogene average gene copy numbers (AGCN); serum CEA and CA 15.3 antigen levels; tumor cells' DNA values), to the ex vivo chemosensitivity of primary female human breast cancer in a modified adenosine triphosphate cell viability chemosensitivity assay (ATP-CVA), was performed. Four drug combinations were tested. A group of 75 cases of female primary breast cancer was assessed. Numerous correlations were found among molecular factors tested but none, with the exception of tumor grading, of these reflected ex vivo chemosensitivity of tumors tested. The results suggest that the parameters tested may not be important factors related to adjuvant chemoresponsiveness of primary human breast cancer to tested drug combinations
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.